Jan Wald
Jan Wald
boston company fda gain permit product quality saying scientific seemed until
What the FDA seemed to be saying is that it doesn't know if Boston Scientific has a systemic, corporate-wide quality policy, and until it does the FDA will not permit the company to gain product approvals in adulterated plants.
company education loses market money training
One thing the company loses by not being part of J&J is not having more money for market development education and training
buying company easy faces growth half impact johnson problem size
The problem that Johnson & Johnson and any company even half the size of Johnson & Johnson faces is buying something that can impact their growth rate, and that's not an easy task.
company hard indication processes
It is another indication that the processes could have been better ? but the company is working hard on it already.
actions company eventually expenses given remain stay
I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish.
certainly company
I certainly think it could be a stand-alone company. I'm not certain it should be.
accused answer both devices medical
In investors' minds, they've been accused of being a one-trick pony, and they don't have a pipeline. If they get Guidant, they answer both those questions. They'll be in one of the fastest-growing medical devices markets, for implantable defibrillators, and they'll have Guidant's pipeline.
bid learnt sensitive
It's still a possibility. But the valuation is high, and one thing we learnt from the J&J bid for Guidant is they are very sensitive to valuation.
bid learned sensitive
It's still a possibility. But the valuation is high, and one thing we learned from the J&J bid for Guidant is they are very sensitive to valuation.
bent
It underscores why they were so bent on doing the Guidant deal.
They were being nickel-and-dimed by J&J. They had to get out of that loop.
boston deal power reach scientific
Boston Scientific will do everything in its power to reach a deal with Guidant.
asked certainly noise questions raised
After all the noise they made, there would certainly be a lot of questions asked (if they raised their bid).
along believe boston deal matter small strategic
I don't believe these things are going to matter for Boston Scientific. This is a strategic deal for them and these are small perturbations along the way.